0001140361-23-010772.txt : 20230308 0001140361-23-010772.hdr.sgml : 20230308 20230308213046 ACCESSION NUMBER: 0001140361-23-010772 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230306 FILED AS OF DATE: 20230308 DATE AS OF CHANGE: 20230308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grossman Jerrold B CENTRAL INDEX KEY: 0001542519 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36728 FILM NUMBER: 23717987 MAIL ADDRESS: STREET 1: 65 COMMERCE WAY CITY: HACKENSACK STATE: NJ ZIP: 07601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADMA BIOLOGICS, INC. CENTRAL INDEX KEY: 0001368514 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 562590442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O ADMA BIOLOGICS, INC. STREET 2: 465 STATE ROUTE 17 CITY: RAMSEY STATE: NJ ZIP: 07446 BUSINESS PHONE: (201) 478-5552 MAIL ADDRESS: STREET 1: C/O ADMA BIOLOGICS, INC. STREET 2: 465 STATE ROUTE 17 CITY: RAMSEY STATE: NJ ZIP: 07446 FORMER COMPANY: FORMER CONFORMED NAME: R&R ACQUISITION VI, INC DATE OF NAME CHANGE: 20060707 4 1 form4.xml X0306 4 2023-03-06 0001368514 ADMA BIOLOGICS, INC. ADMA 0001542519 Grossman Jerrold B C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 true Common Stock 2023-03-06 4 A 0 25815 0 A 313265 D Common Stock 22857 I See Footnote Common Stock 31381 I See Footnote Common Stock 38294 I See Footnote Common Stock 175 I See Footnote Employee Stock Option (right to buy) 3.35 2023-03-06 4 A 0 51630 0 A 2033-03-06 Common Stock 51630 51630 D These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date. Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 13,293 RSUs granted on March 7, 2022, which will vest in full on March 7, 2023; and (iii) 274,157 shares of common stock owned by the reporting person. These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood. These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee. These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis. These shares are owned by the reporting person's wife. The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant. /s/ Dr. Jerrold B. Grossman, by Brian Lenz as Attorney-in-fact 2023-03-08